Table 3. Distribution of homozygous and heterozygous values of c.25+24T>A(rs7515776) polymorphism between severe and non-severe preeclampsia group in preeclampsia and control group.
| Control (n=40) | Preeclampsia | p1 | p2 | OR 95%CI | p3 | p4 | |||
|---|---|---|---|---|---|---|---|---|---|
| All PE (n=35) | Non-severe (n=14) | Severe (n=21) | |||||||
| No polymorphism | 26 (65.0) | 19 (54.3) | 6 (42.9) | 13 (61.9) | 0.046* | 0.345 | 1.56 (0.61–3.96) | 0.109 | 0.339 |
| Polymorphism is present | 14 (35.0) | 16 (45.7) | 8 (57.1) | 8 (38.1) | |||||
| Homozygous | 4 (10.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |||||
| Heterozygous | 10 (25.0) | 16 (45.7) | 8 (57.1) | 8 (38.1) | |||||
Data are given as n (%). p1=control and preeclampsia group with no polymorphism, comparison of homozygous and heterozygous; p2=comparison of control and preeclampsia group with no polymorphism with polymorphism exists; p3=control, severe, and non-severe preeclampsia group with no polymorphism, comparison of homozygous and heterozygous; p4=control, comparison of severe and non-severe preeclampsia group with no polymorphism with polymorphism exists.
*
p<0.05 was accepted as statistically significant.